Retour / Go back

Repligen Europe B.V.

Repligen Europe B.V.

P.O. Box 3262
4800 DG Breda
PAYS BAS
telephone : +31(0) 76 5719 419
fax : +31(0) 76 5719 772
web : www.repligen.com
twitter
linkedin

Our business is influenced by the growth in demand for biologic drugs, particularly the global market for monoclonal antibodies (mAbs). Demand for our products is associated with the overall volume of mAbs manufactured; there is little connection to final drug pricing or the clinical or commercial success or failure of an individual biologic drug.

As the number of biologic drugs on the market and in development continues to increase, and as worldwide access to biologics expands with the emergence of biosimilar and bio-better versions of original drugs, biopharmaceutical manufacturers are tasked with reducing the time and cost associated with production while improving yield and retaining the highest levels of product quality.

These market dynamics are driving process intensification and adoption of disposable technologies and other products that offer convenience, flexibility and the ability to improve capacity utilization in the most modern continuous processing facilities as well as in standard batch processing facilities. The bioprocessing products manufactured by Repligen are designed to address these important needs of biopharmaceutical manufacturers in an increasingly competitive environment.

 

 
Contact(s) :
Devis, Commandes,Questions Techniques et Services Après-Ventes, Formation Europe : REPLIGEN EUROPE B.V. Customer Service Dpt
+31 (0) 76 5719 419
Comptabilité : Nathalie SMARS
+31 (0) 76 5719 419



Horaires et jours d'ouverture :
Bureau ouvert du lundi au vendredi : de 8 heures à 17 heures



La nomenclature de
Repligen Europe B.V. :

achats sur internet - e-purchasing
chromatographie détecteurs - chromatography detectors
chromatographie liquide basse pression - low pressure liquid chromatography
chromatographie pompes - chromatography pumps
colonnes - columns
enregistreurs - sensors
filtration - filtration
filtration échantillons - sample filtration systems
filtration cartouches - filtration cartridges
filtration dispositifs - filtration systems
filtration en ligne - continuous filtration systems
filtration stérilisante - sterilizing filtration
filtration tangentielle - tangential flow filtration
filtres absolus - ultrafilters
filtres à seringue - syringe filters
filtres à usage unique - disposable filters
filtres embouts de seringues - syringe tip filters
injecteurs de chromatographie - chromatography injectors
pompes de laboratoire - pumps for laboratory use
pompes péristaltiques - peristaltic pumps
pompes pour chromatographie - pumps for chromatography
robinets en verre - connectors
spectrophotométrie UV, UV/visible - UV, UV/visible spectrophotometry

Articles publiés dans La gazette du laboratoire

MARS 2014 SPECTRUM LABORATORIES Entretien avec Stéphane ITART-LONGUEVILLE, votre interlocuteur spécialiste des techniques de séparation par membrane, dont la filtration tangentielle à fibres creuses


Repligen Europe B.V.

Repligen Europe B.V.
twitter
linkedin
telephone : +31(0) 76 5719 419
web : www.repligen.com
Contacts :
Devis, Commandes,Questions Techniques et Services Après-Ventes, Formation Europe : REPLIGEN EUROPE B.V. Customer Service Dpt
+31 (0) 76 5719 419
Comptabilité : Nathalie SMARS
+31 (0) 76 5719 419

Contacter la société
en cliquant ici 

Our business is influenced by the growth in demand for biologic drugs, particularly the global market for monoclonal antibodies (mAbs). Demand for our products is associated with the overall volume of mAbs manufactured; there is little connection to final drug pricing or the clinical or commercial success or failure of an individual biologic drug.

As the number of biologic drugs on the market and in development continues to increase, and as worldwide access to biologics expands with the emergence of biosimilar and bio-better versions of original drugs, biopharmaceutical manufacturers are tasked with reducing the time and cost associated with production while improving yield and retaining the highest levels of product quality.

These market dynamics are driving process intensification and adoption of disposable technologies and other products that offer convenience, flexibility and the ability to improve capacity utilization in the most modern continuous processing facilities as well as in standard batch processing facilities. The bioprocessing products manufactured by Repligen are designed to address these important needs of biopharmaceutical manufacturers in an increasingly competitive environment.

 

60 visites depuis 01 janvier 2020